Capital Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338K Sell
1,154
-40
-3% -$13.1K ﹤0.01% 583
2025
Q4
$419K Buy
1,194
+267
+29% +$90.2K 0.01% 515
2025
Q3
$300K Buy
927
+151
+19% +$47K ﹤0.01% 590
2025
Q2
$302K Sell
776
-46
-6% -$18.5K 0.01% 569
2025
Q1
$358K Buy
822
+80
+11% +$32.1K 0.01% 503
2024
Q4
$274K Sell
742
-98
-12% -$41K 0.01% 541
2024
Q3
$437K Sell
840
-21
-2% -$11.2K 0.01% 431
2024
Q2
$467K Buy
861
+27
+3% +$14.3K 0.01% 409
2024
Q1
$432K Sell
834
-53
-6% -$26.4K 0.01% 419
2023
Q4
$418K Buy
887
+22
+3% +$10.2K 0.01% 414
2023
Q3
$377K Sell
865
-273
-24% -$124K 0.01% 413
2023
Q2
$505K Buy
1,138
+273
+32% +$126K 0.02% 339
2023
Q1
$398K Sell
865
-30
-3% -$14.3K 0.01% 389
2022
Q4
$459K Buy
895
+221
+33% +$112K 0.01% 369
2022
Q3
$306K Buy
674
+34
+5% +$16.3K 0.01% 410
2022
Q2
$309K Buy
640
+6
+0.9% +$2.97K 0.01% 417
2022
Q1
$311K Buy
634
+156
+33% +$71.3K 0.01% 449
2021
Q4
$222K Buy
+478
New +$201K 0.01% 534
2019
Q2
Sell
-718
Closed -$206K 515
2019
Q1
$206K Sell
718
-61
-8% -$17.6K 0.01% 451
2018
Q4
$205K Buy
+779
New +$214K 0.01% 434

Other funds holding ELV

Capital Investment Advisors's ELV Position: Q1 2026 in Review

Capital Investment Advisors reduced its Elevance Health (ELV) stake by 3.4% in Q1 2026, selling an estimated $13.1K and leaving 1,154 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #583.

Capital Investment Advisors first reported a position in ELV in Q4 2018 and has held it in 20 quarters since. The position peaked at $505K in Q2 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Capital Investment Advisors held 1,154 shares of Elevance Health worth $338K as of Q1 2026.
  • Capital Investment Advisors sold 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
  • Elevance Health made up ﹤0.01% of Capital Investment Advisors's portfolio in Q1 2026, its #583 holding.
  • Capital Investment Advisors first reported a position in Elevance Health in Q4 2018 and has held it in 20 quarters since.
  • Capital Investment Advisors's Elevance Health position peaked at $505K in Q2 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Capital Investment Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.